Discover our

Services for Media

Are you a media representative looking for content on Bayer? This section provides news, press photos, TV Footage and more.

News

Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195)
February 15, 2019
Not intended for U.S. and UK Media

Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195)

Read more
Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer
February 14, 2019
Not intended for U.S. and UK Media - American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2019

Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer

Read more
Bayer, Netafim and Ben-Gurion University to collaborate on the integration of digital tools for optimizing drip irrigation of the Nematicide Velum™
February 6, 2019
Research collaboration announced at Fruit Logistica 2019 in Berlin:

Bayer, Netafim and Ben-Gurion University to collaborate on the integration of digital tools for optimizing drip irrigation of the Nematicide Velum™

Read more
News Overview
Calendar

Wednesday, February 27, 2019

Integrated Annual Report 2018

Financial News Conference on the Full Year 2018 Results

Our Services

Publications

Get easy access to the different reports, magazines and brochures from Bayer.

Newsletter

We will keep you informed about the latest news

Our Media Streams

Social Media Overview